SCHEMBL6678030

SCHEMBL6678030

CCN=C(N)Nc1cccc(CN(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 16/20 0.44
GRIN2D O15399 2/20 0.42
GRIN3B O60391 2/20 0.42
GRIN1 Q05586 2/20 0.42
GRIN2A Q12879 2/20 0.42
GRIN2B Q13224 2/20 0.42
GRIN2C Q14957 2/20 0.42
GRIN3A Q8TCU5 2/20 0.42
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41
CACNA1C Q13936 1/20 0.40
SCN5A Q14524 1/20 0.40
GRM2 Q14416 1/20 0.39
BACE1 P56817 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6679168 0.91 ADRA2A (0.43) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6690435 0.89 NOS3 (0.53) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7243106 0.87 SIGMAR1 (0.39) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6677790 0.84 ALDH1A1 (0.47) SIGMAR1GRM2BACE1
SCHEMBL6676788 0.81 BACE1 (0.38) NOS3NOS1NOS2GRM2BACE1
SCHEMBL6690431 0.81 BACE1 (0.41) GRM2BACE1
SCHEMBL6674967 0.79 GRM2 (0.38) SIGMAR1NOS3NOS1NOS2GRM2
SCHEMBL6676657 0.79 CYP3A4 (0.47) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6678027 0.79 BACE1 (0.40) GRM2BACE1
SCHEMBL6676782 0.78 BACE1 (0.41) GRM2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0798292-B1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY CHUGAI SEIYAKUKABUSHIKI KAISHA (JP) 2004-11-03 EP disclosed
US-6534546-B1 Guanidine- or isothioureido-N-derived anilines; brain, nervous system, and neurodegenerative disorders CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-18 US disclosed
EP-0798292-A1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY Chugai Seiyaku Kabushiki Kaisha (JP) 1997-10-01 EP disclosed